default author photo

Dan Nordström

University of Helsinki - Helsinki University Hospital

SCHOLARLY PAPERS

3

DOWNLOADS

185

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Certolizumab pegol, Abatacept, Tocilizumab or Active Conventional Therapy in Early Rheumatoid Arthritis: 48 Week Patient-Reported Outcomes of the NORD-STAR Trial

Number of pages: 26 Posted: 07 Oct 2025
Karolinska Institutet, University of Helsinki - Helsinki University Hospital, University of Amsterdam - Department of Rheumatology and Clinical Immunology, University of Copenhagen - Department of Clinical Medicine, Diakonhjemmet Hospital, University of Copenhagen, University of Gothenburg - Department of Rheumatology and Inflammation Research, Diakonhjemmet Hospital, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Landspitali University Hospital, Karolinska Institutet, University of Southern Denmark, University of Eastern Finland, University of Iceland, University of Copenhagen, Karolinska University Hospital, Sahlgrenska University Hospital, University of Eastern Finland, Lund University, Karolinska Institutet, Diakonhjemmet Hospital, Helsinki University Hospital, Silkeborg Regional Hospital - Diagnostic Centre, Lund University, Uppsala University - Uppsala University Hospital, University of Southern Denmark, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, Falun Hospital, Ålesund Hospital, University of Bergen - Haukeland University Hospital, Odense University Hospital, Örebro University Hospital, Västmanland´s Hospital, Linkoping University, Karolinska Institutet, Aalborg University, Odense University Hospital, Trondheim University Hospital, Aarhus University, University Hospital of North Norway - Department of Rheumatology, University of Oslo - Department of Research Support for Clinical Trials, Diakonhjemmet Hospital and Diakonhjemmet Hospital
Downloads 92 (730,864)

Abstract:

Loading...

Arthritis, Rheumatoid arthritis, Patient reported outcome, Pain, Fatigue, Biologic drug, TNF, Il-6, Abatacept, Remission

2.

Acylcarnitine Enrichment as a Characteristic of Rheumatoid Arthritis Fibroblast-Like Synoviocyte Metabolic Fingerprint

Number of pages: 29 Posted: 12 May 2025
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Amsterdam - Department of Rheumatology and Clinical Immunology, Karolinska Institutet, Landspitali University Hospital, Diakonhjemmet Hospital, University of Helsinki - Helsinki University Hospital, University of Iceland, University of Southern Denmark, University of Eastern Finland, Karolinska Institutet, University of Copenhagen - Department of Clinical Medicine, University of Amsterdam - Amsterdam Rheumatology and Immunology Centre, University of Copenhagen, Diakonhjemmet Hospital, University of Gothenburg - Department of Rheumatology and Inflammation Research, University of Gothenburg - Department of Molecular and Clinical Medicine, University of California, San Diego (UCSD) - Department of Cellular & Molecular Medicine and affiliation not provided to SSRN
Downloads 52 (1,041,696)

Abstract:

Loading...

rheumatoid arthritis, Fibroblast-like synoviocytes, metabolomics, acylcarnitines

3.

Evolution of Janus Kinase inhibitors (JAKi) prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study): effect of regulatory warnings

Number of pages: 28 Posted: 09 Oct 2025
affiliation not provided to SSRN, University of Geneva - Geneva University Hospitals, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Medicine and Pharmacy Carol Davila Bucharest, UOD Reumatologia- Grande Ospedale Metropolitano, Diakonhjemmet Hospital - Center for treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, affiliation not provided to SSRN, University of Helsinki - Helsinki University Hospital, Institute of Rheumatology, Institute of Rheumatology, INCLIVA Health Research Institute - Hospital Clínico Universitario, Spanish Society of Rheumatology, Faculdade de Medicina da Universidade de Lisboa, University of Ljubljana, Foundation for Research and Technology - Hellas (FORTH) - Institute of Molecular Biology and Biotechnology (IMBB), University of Crete - Rheumatology, Clinical Immunology and Allergy Department, University of Geneva - Geneva University Hospitals, affiliation not provided to SSRN, affiliation not provided to SSRN, Tel Aviv University and Tel Aviv University
Downloads 41 (1,170,409)

Abstract:

Loading...